Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Specializing in the metabolism of polyunsaturated fatty acids (PUFAs), ACSL4 has emerged as a key modulator of ferroptosis sensitivity [43]
- **Place of service and reimbursement rates**: As a Drugs Administered Other than Oral Method service requiring moderate medical decision-making, J1559 falls under Medicare Part Bs scope
[PMID: 4088069] PubMed record related to this compound for laboratory literature review
yv;UAS ND-75 RNAi (#27739)
Published clinical trials on injectable skin outcomes are limited
US$ 22.45
US$ 20.05
US$ 20.68
US$ 21.11
